 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1y7j
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Nmr structure family of human agouti signalling protein (80- 132: q115y, s124y)
|
|
Structure:
|
 |
Agouti signaling protein. Chain: a. Fragment: residies 80-132. Synonym: agouti switch protein. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Synthetic: yes. Other_details: sequence occurs naturally in humans, genes asip, agti, agtil, asp
|
|
NMR struc:
|
 |
21 models
|
 |
|
Authors:
|
 |
J.C.Mcnulty,P.J.Jackson,D.A.Thompson,B.Chai,I.Gantz, G.S.Barsh,P.E.Dawson,G.L.Millhauser
|
Key ref:
|
 |
J.C.McNulty
et al.
(2005).
Structures of the agouti signaling protein.
J Mol Biol,
346,
1059-1070.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Dec-04
|
Release date:
|
15-Feb-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P42127
(ASIP_HUMAN) -
Agouti-signaling protein
|
|
|
|
Seq: Struc:
|
 |
 |
 |
132 a.a.
40 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biological process
|
hormone-mediated signaling
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
346:1059-1070
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of the agouti signaling protein.
|
|
J.C.McNulty,
P.J.Jackson,
D.A.Thompson,
B.Chai,
I.Gantz,
G.S.Barsh,
P.E.Dawson,
G.L.Millhauser.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Expression of the agouti signaling protein (ASIP) during hair growth produces
the red/yellow pigment pheomelanin. ASIP, and its neuropeptide homolog the
agouti-related protein (AgRP) involved in energy balance, are novel, paracrine
signaling molecules that act as inverse agonists at distinct subsets of
melanocortin receptors. Ubiquitous ASIP expression in mice gives rise to a
pleiotropic phenotype characterized by a uniform yellow coat color, obesity,
overgrowth, and metabolic derangements similar to type II diabetes in humans.
Here we report the synthesis and NMR structure of ASIP's active, cysteine-rich,
C-terminal domain. ASIP adopts the inhibitor cystine knot fold and, along with
AgRP, are the only known mammalian proteins in this structure class. Moreover,
ASIP populates two distinct conformers resulting from a cis peptide bond at
Pro102-Pro103 and a coexistence of cis/trans isomers of Ala104-Pro105.
Pharmacologic studies of Pro-->Ala mutants demonstrate that the minor
conformation with two cis peptide bonds is responsible for activity at all MCRs.
The loop containing the heterogeneous Ala-Pro peptide bond is conserved in
mammals, and suggests that ASIP is either trapped by evolution in this unusual
configuration or possesses function outside of strict MCR antagonism.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. (a) Summary of backbone-backbone NOEs (arrows)
and HX protection (thick lines between NH donors and CO
acceptors) in the b-sheet region. (b) Sausage diagrams obtained
from the 20 lowest energy structures for both cis ASIP-YY and
trans ASIP-YY.
|
 |
Figure 4.
Figure 4. Structure of ASIP-YY. Ribbon diagrams of cis (a),
and trans ASIP-YY (b). For clarity, cysteine residues involved
in disulfide bonds are labeled in the cis ASIP-YY structure and
relevant loops are labeled in the trans ASIP-YY structure. Also
noted is the threading disulfide indicative of the ICK fold
motif. In (c), cis and trans ASIP-YY are shown superimposed with
their b-sheets aligned. The persistent cis Pro102-Pro103 peptide
bond and the peptide bond between Ala104 and Pro105 that
switches between cis and trans in the two global structures are
labeled. In (d), cis ASIP-YY and AgRP(87-132) are superimposed.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2005,
346,
1059-1070)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.J.Kim,
Y.H.Lee,
M.D.Han,
W.Mar,
W.K.Kim,
and
K.W.Nam
(2010).
Resveratrol, purified from the stem of Vitis coignetiae Pulliat, inhibits food intake in C57BL/6J Mice.
|
| |
Arch Pharm Res, 33,
775-780.
|
 |
|
|
|
|
 |
W.C.Wong,
S.Maurer-Stroh,
and
F.Eisenhaber
(2010).
More than 1,001 problems with protein domain databases: transmembrane regions, signal peptides and the issue of sequence homology.
|
| |
PLoS Comput Biol, 6,
e1000867.
|
 |
|
|
|
|
 |
A.Alizadeh,
L.Z.Hong,
C.B.Kaelin,
T.Raudsepp,
H.Manuel,
and
G.S.Barsh
(2009).
Genetics of Sex-linked yellow in the Syrian hamster.
|
| |
Genetics, 181,
1427-1436.
|
 |
|
|
|
|
 |
C.Haskell-Luevano,
J.W.Schaub,
A.Andreasen,
K.R.Haskell,
M.C.Moore,
L.M.Koerper,
F.Rouzaud,
H.V.Baker,
W.J.Millard,
G.Walter,
S.A.Litherland,
and
Z.Xiang
(2009).
Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.
|
| |
FASEB J, 23,
642-655.
|
 |
|
|
|
|
 |
H.Qu,
M.Cai,
A.V.Mayorov,
P.Grieco,
M.Zingsheim,
D.Trivedi,
and
V.J.Hruby
(2009).
Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.
|
| |
J Med Chem, 52,
3627-3635.
|
 |
|
|
|
|
 |
T.Hida,
K.Wakamatsu,
E.V.Sviderskaya,
A.J.Donkin,
L.Montoliu,
M.Lynn Lamoreux,
B.Yu,
G.L.Millhauser,
S.Ito,
G.S.Barsh,
K.Jimbow,
and
D.C.Bennett
(2009).
Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.
|
| |
Pigment Cell Melanoma Res, 22,
623-634.
|
 |
|
|
|
|
 |
A.Heitz,
O.Avrutina,
D.Le-Nguyen,
U.Diederichsen,
J.F.Hernandez,
J.Gracy,
H.Kolmar,
and
L.Chiche
(2008).
Knottin cyclization: Impact on Structure and Dynamics.
|
| |
BMC Struct Biol, 8,
54.
|
 |
|
|
|
|
 |
C.B.Kaelin,
S.I.Candille,
B.Yu,
P.Jackson,
D.A.Thompson,
M.A.Nix,
J.Binkley,
G.L.Millhauser,
and
G.S.Barsh
(2008).
New ligands for melanocortin receptors.
|
| |
Int J Obes (Lond), 32,
S19-S27.
|
 |
|
|
|
|
 |
D.Enshell-Seijffers,
C.Lindon,
and
B.A.Morgan
(2008).
The serine protease Corin is a novel modifier of the Agouti pathway.
|
| |
Development, 135,
217-225.
|
 |
|
|
|
|
 |
B.Yu,
and
G.L.Millhauser
(2007).
Chemical disulfide mapping identifies an inhibitor cystine knot in the agouti signaling protein.
|
| |
FEBS Lett, 581,
5561-5565.
|
 |
|
|
|
|
 |
S.I.Candille,
C.B.Kaelin,
B.M.Cattanach,
B.Yu,
D.A.Thompson,
M.A.Nix,
J.A.Kerns,
S.M.Schmutz,
G.L.Millhauser,
and
G.S.Barsh
(2007).
A -defensin mutation causes black coat color in domestic dogs.
|
| |
Science, 318,
1418-1423.
|
 |
|
|
|
|
 |
S.Krause,
H.U.Schmoldt,
A.Wentzel,
M.Ballmaier,
K.Friedrich,
and
H.Kolmar
(2007).
Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists.
|
| |
FEBS J, 274,
86-95.
|
 |
|
|
|
|
 |
H.Y.Meng,
K.M.Thomas,
A.E.Lee,
and
N.J.Zondlo
(2006).
Effects of i and i+3 residue identity on cis-trans isomerism of the aromatic(i+1)-prolyl(i+2) amide bond: implications for type VI beta-turn formation.
|
| |
Biopolymers, 84,
192-204.
|
 |
|
|
|
|
 |
N.I.Mundy,
and
J.Kelly
(2006).
Investigation of the role of the agouti signaling protein gene (ASIP) in coat color evolution in primates.
|
| |
Mamm Genome, 17,
1205-1213.
|
 |
|
|
|
|
 |
P.J.Jackson,
N.R.Douglas,
B.Chai,
J.Binkley,
A.Sidow,
G.S.Barsh,
and
G.L.Millhauser
(2006).
Structural and molecular evolutionary analysis of Agouti and Agouti-related proteins.
|
| |
Chem Biol, 13,
1297-1305.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|